In the present study, a novel mechanism was revealed whereby PRMT5 inhibition promotes CPT‐11 sensitivity and synergistically induces a dMMR‐like state in MSS CRC, further activating the cGAS‐STING signaling pathway and boosting anti‐tumor immunity. Here, PRMT5 is linked to neoplasm.